Inovio Pharmaceuticals (INO) Reports Mixed Q3 Results
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.29 +4.03%
EPS Growth %: +75.9%
Financial Fact:
Total revenue: 12.54M
Today's EPS Names:
NEOV, MANU, CTAS, More
EPS Growth %: +75.9%
Financial Fact:
Total revenue: 12.54M
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $2.64 million versus the consensus estimate of $1.87 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- LuxExperience B.V. (LUXE) Misses Q2 EPS by 11c
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
